FDA announces changes affecting the marketing of non-steroidal anti-inflammatory drugs. From: FDA Consumer | Date: May 1, 2005 | COPYRIGHT 2005 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

The Food and Drug Administration has announced a series of important changes pertaining to the marketing of the non-steroidal anti-inflammatory class of drugs (NSAIDs).

On April 7, 2005, the FDA issued a public health advisory and updated patient and health care practitioner fact sheets for COX-2 selective and prescription and non-prescription non-selective NSAID medications.

The FDA also asked Pfizer Inc. of New York City to withdraw Bextra (valdecoxib) from the market because the overall risk versus benefit profile for the drug is unfavorable. In addition, the agency ...

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

	Boxed warning: renal fibrosis risk with gadolinium contrast agents.(News) ; ...Administration has requested that a boxed warning explaining the increased risk...addition, the alert states that the FDA has requested that the manufacturers...transplantation period, according to the FDA. Dr. Shawn E. Cowper, assistant...told SKIN & ALLERGY NEWS. FDA is advising that ...
	FDA: Xolair must be given under supervision.(News) ; ...new requirements, including a boxed warning, for Xolair (omalizumab). Approved...treatment, according to the FDA. Because of this risk, Xolair...guidelines are included in a boxed warning, warnings and precautions...adverse reaction, visit www.fda.gov/medwatch/safety/2007/ safety07...
	A TIP FROM FDA LED TO SEC'S SUIT AGAINST BIOPURE ; The FDA dropped the dime. According to a government...and several executives hid from investors the FDA's safety concerns about its products while...effects of the closer cooperation between the FDA and the SEC to police biotechnology companies...
	Boxed warning for Regranex.(Practice Issues)(Brief article) ; ...announced the addition of a boxed warning to the label of Regranex Gel...been updated to include a BOXED WARNING and a description of the epidemiologic...announcing this label change, FDA still cautions health care...To read about Regranex and FDA's follow-up communication...Regranex ...
	FDA boosts estrogen, progestin warnings. (Washington Insider).(Brief Article) ; The FDA has strengthened the labeling for estrogen and estrogen/progestin products to include a new boxed warning that cautions against using the products for the prevention of cardiovascular disease and recommending that they be prescribed at the lowest effective doses and for the shortest duration ...
	FDA approves black box for Elidel and Protopic.(Dermatologic Therapy) ; ...came almost a year after the FDA's Pediatric Advisory Committee...the label be updated with a boxed warning and a medication guide about...it is a reevaluation by the FDA to say that the causal relationship...Inc.). The FDA felt that the boxed warning and medication guide ...
	FDA, SEC link up on false statements to public. ; Dear Reader, FDA and the Securities and Exchange Com-mission have developed a closer partnership, whereby FDA will provide SEC with information about potential...executives concealed the fact from investors that FDA would not be approving its drug, Erbitux...
	FDA panels reject suicidality warning for antiepileptic drugs.(News) ; BELTSVILLE, MD. -- A boxed warning about an increased suicidality risk...14-4 with 3 abstentions against the FDA's proposal to include it in a black...that the finding be included in a boxed warning added to the labels of all currently...
	FDA, Bayer issue letter to doctors about MRI agents.(Warnings/recalls)(Bayer HealthCare L.L.C.)(magnetic resonance imaging)(Brief article) ; Bayer Healthcare and FDA issued a Dear Healthcare Professional...notify of the addition of a BOXED WARNING and revisions to the WARNING...contrast agents are approved by FDA for use in MRI. Post-marketing...revised to include the following Boxed Warning and update to the ...
	Boxed warning added to diabetic foot and leg ulcer drug.(News) ; ...becaplermin is now included in a boxed warning on the label of the diabetic...diabetic leg and foot ulcers. The boxed warning says that the increased risk...letter said. Links to the FDA's update and the company's letter can be found at www.fda.gov/cder/drug/infopage/becaplermin...at ...

For more facts and information, see all results